Sunday, September 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Amgen Stock: Strong Earnings Overshadowed by Drug Doubts

Felix Baarz by Felix Baarz
August 6, 2025
in Stocks
0
Amgen Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Amgen reported stellar quarterly results, with revenue surging 9% to $9.2 billion—exceeding analyst expectations—and adjusted earnings per share jumping 21% to $6.02. The biotech giant also raised its full-year guidance, projecting revenue between $35-$36 billion and higher EPS estimates. However, shares fell nearly 5% as investor enthusiasm was dampened by concerns over its experimental weight-loss drug, MariTide. Analysts questioned its competitiveness against dominant rivals like Ozempic, casting doubt on Amgen’s ability to capitalize on this high-growth market.

Pipeline Performance Under Scrutiny

While drugs like cholesterol treatment Repatha saw sales soar 31% to $696 million, declining revenue for bone therapy Prolia (-4%) highlighted competitive pressures. Despite heavy R&D investment (up 18%), MariTide remains a key uncertainty, with critical trial data expected later this year. The stock, though up 10% year-to-date, lags behind broader indices, reflecting deeper skepticism about Amgen’s long-term growth strategy amid shifting market dynamics.

Ad

Amgen Stock: Buy or Sell?! New Amgen Analysis from September 21 delivers the answer:

The latest Amgen figures speak for themselves: Urgent action needed for Amgen investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 21.

Amgen: Buy or sell? Read more here...

Tags: Amgen
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Quantum Computing Stock
Stocks

Quantum Computing Stock Dips Despite Major Contract Wins

September 16, 2025
Coinbase Stock
Stocks

Institutional Partnership Fuels Optimism for Coinbase’s Future

September 16, 2025
Strategy Stock
Stocks

MicroStrategy’s Bitcoin Bet Faces Market Skepticism

September 16, 2025
Next Post
Onward MedicalV Stock

Onward MedicalV Stock: Neurotech Firm Taps Medtech Veteran for Growth

NiSource Stock

NiSource Stock: Strong Earnings Beat Amid Cautious Market Reaction

General Motors Stock

General Motors Stock: Strategic Shifts Boost Market Confidence

Recommended

Childrens Place Stock

Children’s Place Faces Pivotal Earnings Test Amid Strategic Overhaul

2 weeks ago
Finances-and-tech

Analyzing Viper Energys Short Interest A Key Indicator of Market Sentiment

2 years ago
Silicon Motion Stock

The Unseen Engine: Silicon Motion Powers Next-Generation AI and Automotive Innovation

1 week ago
Gorman-Rupp Stock

Gorman-Rupp Shares Maintain Upward Trajectory Amid Market Volatility

4 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

W. R. Berkley Strengthens Niche Market Strategy with Key Appointment

Institutional Confidence in MiMedx Remains Strong Despite Share Price Dip

White House Flexes Unprecedented Authority to Halt US Steel Plant Closure

Leadership Shakeup Concludes as Opendoor Shares Maintain Meteoric Rise

Nuclear Renaissance Fuels Centrus Energy’s Meteoric Ascent

Ameren Shares Gain Momentum on Analyst Upgrade and Strategic Moves

Trending

Hyliion Holdings Stock
Analysis

Three Catalysts That Could Signal a Turnaround for Hyliion Stock

by Robert Sasse
September 21, 2025
0

Hyliion Holdings Corp. is showing signs of a potential resurgence, buoyed by a series of recent strategic...

Seneca Foods Stock

Seneca Foods Stock: A Clash Between Technical Momentum and Fundamental Concerns

September 21, 2025
Micron Stock

Wall Street Analysts Rally Behind Micron Stock Ahead of Earnings

September 21, 2025
Berkley Stock

W. R. Berkley Strengthens Niche Market Strategy with Key Appointment

September 21, 2025
MiMedx Stock

Institutional Confidence in MiMedx Remains Strong Despite Share Price Dip

September 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Three Catalysts That Could Signal a Turnaround for Hyliion Stock
  • Seneca Foods Stock: A Clash Between Technical Momentum and Fundamental Concerns
  • Wall Street Analysts Rally Behind Micron Stock Ahead of Earnings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com